In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...
(Reuters) - Johnson & Johnson (NYSE: JNJ) said on Monday it had filed a lawsuit against Samsung (KS: 005930) Bioepis for breaching its contract agreement with the drugmaker over the launch of a ...
Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...
Deep Dive Into Archer-Daniels Midland Stock: Analyst Perspectives (9 Ratings) Deep Dive Into Chemours Stock: Analyst Perspectives (7 Ratings) What 39 Analyst Ratings Have To Say About Salesforce ...
Johnson & Johnson (JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J ...
Samsung Electronics Co. Ltd.-0.35% ₩381.57T ...
LG H&H Co. Ltd.-0.91% ₩5.06T LG H&H Co. Ltd. Pfd. Series 1 0.31% ₩5.06T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback